-
1
-
-
0027319465
-
Vasculitis and cancer
-
Kurzrock R., and Cohen P. Vasculitis and cancer. Clin. Dermatol. 11 1 (1993) 175-187
-
(1993)
Clin. Dermatol.
, vol.11
, Issue.1
, pp. 175-187
-
-
Kurzrock, R.1
Cohen, P.2
-
2
-
-
0028069683
-
Clinical manifestations of vasculitis in patients with solid tumors
-
Kurzrock R., Cohen P., and Markowitz A. Clinical manifestations of vasculitis in patients with solid tumors. Arch. Intern. Medical. 154 3 (1994) 334-340
-
(1994)
Arch. Intern. Medical.
, vol.154
, Issue.3
, pp. 334-340
-
-
Kurzrock, R.1
Cohen, P.2
Markowitz, A.3
-
3
-
-
1342287488
-
Cyclic lymphocytic vasculitis associated with chronic lymphocytic leukemia
-
Cabuk M., et al. Cyclic lymphocytic vasculitis associated with chronic lymphocytic leukemia. Leuk. Lymphoma. 45 4 (2004) 811-813
-
(2004)
Leuk. Lymphoma.
, vol.45
, Issue.4
, pp. 811-813
-
-
Cabuk, M.1
-
4
-
-
0027384254
-
The spectrum of cutaneous disease in leukemias
-
Desch J., and Smoller B. The spectrum of cutaneous disease in leukemias. J. Cutan. Pathol. 20 5 (1993) 407-410
-
(1993)
J. Cutan. Pathol.
, vol.20
, Issue.5
, pp. 407-410
-
-
Desch, J.1
Smoller, B.2
-
5
-
-
33644825973
-
Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis
-
Carlson J., Ng B., and Chen K. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am. J. Dermatopathol. 27 6 (2005) 504-528
-
(2005)
Am. J. Dermatopathol.
, vol.27
, Issue.6
, pp. 504-528
-
-
Carlson, J.1
Ng, B.2
Chen, K.3
-
6
-
-
0034091299
-
Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies
-
Choi H., et al. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis. Rheum. 43 2 (2000) 405-413
-
(2000)
Arthritis. Rheum.
, vol.43
, Issue.2
, pp. 405-413
-
-
Choi, H.1
-
7
-
-
0031006210
-
Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature
-
Kitahara T., et al. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature. Clin. Nephrol. 47 5 (1997) 336-340
-
(1997)
Clin. Nephrol.
, vol.47
, Issue.5
, pp. 336-340
-
-
Kitahara, T.1
-
8
-
-
40349116031
-
Drug-induced vasculitis
-
Wiik A. Drug-induced vasculitis. Curr. Opin. Rheumatol. 20 (2008) 35-39
-
(2008)
Curr. Opin. Rheumatol.
, vol.20
, pp. 35-39
-
-
Wiik, A.1
-
9
-
-
0036143936
-
Cutaneous and systemic manifestations of drug-induced vasculitis
-
ten Holder S., Joy M., and Falk R. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann. Pharmacother. 36 1 (2002) 130-147
-
(2002)
Ann. Pharmacother.
, vol.36
, Issue.1
, pp. 130-147
-
-
ten Holder, S.1
Joy, M.2
Falk, R.3
-
10
-
-
0036022549
-
Methimazole-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous systemic lupus erythematosus
-
Thong H., Chu C., and Chiu H. Methimazole-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous systemic lupus erythematosus. Acta. Derm. Venereol. 82 3 (2002) 206-208
-
(2002)
Acta. Derm. Venereol.
, vol.82
, Issue.3
, pp. 206-208
-
-
Thong, H.1
Chu, C.2
Chiu, H.3
-
11
-
-
0036176961
-
Anti-neutrophil cytoplasmic autoantibody (ANCA) profiles in propylthiouracil-induced lupus-like manifestations in monozygotic triplets with hyperthyroidism
-
Herlin T., et al. Anti-neutrophil cytoplasmic autoantibody (ANCA) profiles in propylthiouracil-induced lupus-like manifestations in monozygotic triplets with hyperthyroidism. Scand. J. Rheumatol. 31 1 (2002) 46-49
-
(2002)
Scand. J. Rheumatol.
, vol.31
, Issue.1
, pp. 46-49
-
-
Herlin, T.1
-
12
-
-
0034527641
-
High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil
-
Sato H., et al. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. J. Clin. Endocrinol. Metab. 85 11 (2000) 4270-4273
-
(2000)
J. Clin. Endocrinol. Metab.
, vol.85
, Issue.11
, pp. 4270-4273
-
-
Sato, H.1
-
13
-
-
0024337144
-
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
-
Slamon D., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 4905 (1989) 707-712
-
(1989)
Science
, vol.244
, Issue.4905
, pp. 707-712
-
-
Slamon, D.1
-
14
-
-
0034871354
-
HER2 as a prognostic and predictive marker for breast cancer
-
Cooke T., et al. HER2 as a prognostic and predictive marker for breast cancer. Ann. Oncol. 12 Suppl 1 (2001) S23-28
-
(2001)
Ann. Oncol.
, vol.12
, Issue.SUPPL. 1
-
-
Cooke, T.1
-
15
-
-
4143112475
-
Pharmacological background of EGFR targeting
-
Castillo L., et al. Pharmacological background of EGFR targeting. Ann. Oncol. 15 7 (2004) 1007-1112
-
(2004)
Ann. Oncol.
, vol.15
, Issue.7
, pp. 1007-1112
-
-
Castillo, L.1
-
16
-
-
0034773992
-
The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities
-
Yarden Y. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur. J. Cancer. 37 Suppl 4 (2001) S3-8
-
(2001)
Eur. J. Cancer.
, vol.37
, Issue.SUPPL. 4
-
-
Yarden, Y.1
-
17
-
-
40849147041
-
EGFR antagonists in cancer treatment
-
Ciardiello F., and Tortora G. EGFR antagonists in cancer treatment. N. Engl. J. Med. 358 11 (2008) 1160-1174
-
(2008)
N. Engl. J. Med.
, vol.358
, Issue.11
, pp. 1160-1174
-
-
Ciardiello, F.1
Tortora, G.2
-
18
-
-
0026583746
-
Cyclin A is required at two points in the human cell cycle
-
Pagano M., et al. Cyclin A is required at two points in the human cell cycle. EMBO. J. 11 3 (1992) 961-971
-
(1992)
EMBO. J.
, vol.11
, Issue.3
, pp. 961-971
-
-
Pagano, M.1
-
19
-
-
0034864042
-
Chromatin assembly and organization
-
Ridgway P., and Almouzni G. Chromatin assembly and organization. J. Cell. Sci. 114 Pt 15 (2001) 2711-2712
-
(2001)
J. Cell. Sci.
, vol.114
, Issue.PART 15
, pp. 2711-2712
-
-
Ridgway, P.1
Almouzni, G.2
-
20
-
-
33747868707
-
Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway
-
Le X., et al. Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway. Cell. Cycle. 5 15 (2006) 1654-1661
-
(2006)
Cell. Cycle.
, vol.5
, Issue.15
, pp. 1654-1661
-
-
Le, X.1
-
21
-
-
0034665757
-
NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription
-
Zhao J., et al. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev. 14 18 (2000) 2283-2297
-
(2000)
Genes Dev.
, vol.14
, Issue.18
, pp. 2283-2297
-
-
Zhao, J.1
-
22
-
-
8644219655
-
Living with or without cyclins and cyclin-dependent kinases
-
Sherr C., and Roberts J. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 18 22 (2004) 2699-2711
-
(2004)
Genes Dev.
, vol.18
, Issue.22
, pp. 2699-2711
-
-
Sherr, C.1
Roberts, J.2
-
23
-
-
33644635247
-
A review of EGFR targeted therapy
-
Baselga J. A review of EGFR targeted therapy. Clin. Adv. Hematol. Oncol. 1 14 (2003) 218-219
-
(2003)
Clin. Adv. Hematol. Oncol.
, vol.1
, Issue.14
, pp. 218-219
-
-
Baselga, J.1
-
24
-
-
0035724536
-
Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225
-
Busam K., et al. Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225. Br. J. Dermatol. 144 6 (2001) 1169-1176
-
(2001)
Br. J. Dermatol.
, vol.144
, Issue.6
, pp. 1169-1176
-
-
Busam, K.1
-
25
-
-
0036051312
-
Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor
-
Van Doorn R., et al. Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor. Br. J. Dermatol. 147 3 (2002) 598-601
-
(2002)
Br. J. Dermatol.
, vol.147
, Issue.3
, pp. 598-601
-
-
Van Doorn, R.1
-
26
-
-
26944467607
-
Management of EGFR-inhibiotr-related skin reactions
-
Segaert S., et al. Management of EGFR-inhibiotr-related skin reactions. J. Dtsch. Dermatol. Ges. 3 8 (2005) 599-606
-
(2005)
J. Dtsch. Dermatol. Ges.
, vol.3
, Issue.8
, pp. 599-606
-
-
Segaert, S.1
-
27
-
-
34548395965
-
Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib
-
Boeck S., Wollenberg A., and Heinemann V. Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib. Ann. Oncol. 18 9 (2007) 1582-1583
-
(2007)
Ann. Oncol.
, vol.18
, Issue.9
, pp. 1582-1583
-
-
Boeck, S.1
Wollenberg, A.2
Heinemann, V.3
-
28
-
-
33750584030
-
HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy
-
Wen X., et al. HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy. Oncogene 2 25 (2006) 6986-6996
-
(2006)
Oncogene
, vol.2
, Issue.25
, pp. 6986-6996
-
-
Wen, X.1
-
29
-
-
0036139727
-
Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition
-
Albanell J., et al. Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition. J. Clin. Oncol. 1 20 (2002)
-
(2002)
J. Clin. Oncol.
, vol.1
, Issue.20
-
-
Albanell, J.1
-
30
-
-
5044223956
-
A review of adjuvant hormonal therapy in breast cancer
-
Jones K., and Buzdar A. A review of adjuvant hormonal therapy in breast cancer. Endocrine-related Cancer 11 (2004) 392-406
-
(2004)
Endocrine-related Cancer
, vol.11
, pp. 392-406
-
-
Jones, K.1
Buzdar, A.2
-
31
-
-
33846971221
-
Tamoxifen-associated vasculitis in a breast cancer patient
-
(5)
-
Candelaria M., et al. Tamoxifen-associated vasculitis in a breast cancer patient. World. J. Surg. Oncol. 23 5 (2007) 9 (5)
-
(2007)
World. J. Surg. Oncol.
, vol.23
, Issue.5
, pp. 9
-
-
Candelaria, M.1
-
32
-
-
33846518466
-
Henoch-Schönlein purpura (HSP) during treatment with anastrozole
-
Conti-Beltraminelli M., et al. Henoch-Schönlein purpura (HSP) during treatment with anastrozole. Annals of Oncology 18 1 (2007) 205-207
-
(2007)
Annals of Oncology
, vol.18
, Issue.1
, pp. 205-207
-
-
Conti-Beltraminelli, M.1
-
33
-
-
0025321905
-
Tamoxifen and purpuric vasculitis
-
Drago F., Arditi M., and Rebora A. Tamoxifen and purpuric vasculitis. Ann. Intern. Med. 112 12 (1990) 965-966
-
(1990)
Ann. Intern. Med.
, vol.112
, Issue.12
, pp. 965-966
-
-
Drago, F.1
Arditi, M.2
Rebora, A.3
-
34
-
-
16344387532
-
Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment
-
Shoda H., et al. Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment. Ann. Rheum. Dis. 64 (2005) 651-652
-
(2005)
Ann. Rheum. Dis.
, vol.64
, pp. 651-652
-
-
Shoda, H.1
-
35
-
-
0022617357
-
Cutaneous paraneoplastic syndromes
-
McLean D. Cutaneous paraneoplastic syndromes. Arch. Dermatol. 122 (1986) 765-767
-
(1986)
Arch. Dermatol.
, vol.122
, pp. 765-767
-
-
McLean, D.1
-
36
-
-
34848867563
-
Cutaneous vasculitis as a paraneoplastic syndrome in childhood
-
Pelajo C., et al. Cutaneous vasculitis as a paraneoplastic syndrome in childhood. Acta. Reumatol. Port. 32 2 (2007) 181-183
-
(2007)
Acta. Reumatol. Port.
, vol.32
, Issue.2
, pp. 181-183
-
-
Pelajo, C.1
-
37
-
-
0025243457
-
Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature.
-
Sánchez-Guerrero J., et al. Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature. J. Rheumatol. 17 11 (1990) 1458-1462
-
(1990)
J. Rheumatol.
, vol.17
, Issue.11
, pp. 1458-1462
-
-
Sánchez-Guerrero, J.1
-
38
-
-
0023811560
-
Vasculitis associated with malignancy. Experience with 13 patients and literature review.
-
Greer J., et al. Vasculitis associated with malignancy. Experience with 13 patients and literature review. Med. (Baltimore) 67 4 (1988) 220-230
-
(1988)
Med. (Baltimore)
, vol.67
, Issue.4
, pp. 220-230
-
-
Greer, J.1
-
39
-
-
0031415976
-
Systemic vasculitis and epithelioma
-
Hayem G., et al. Systemic vasculitis and epithelioma. Rev. Rhum. Engl. Ed. 64 12 (1997) 816-824
-
(1997)
Rev. Rhum. Engl. Ed.
, vol.64
, Issue.12
, pp. 816-824
-
-
Hayem, G.1
-
40
-
-
0030045912
-
Paraneoplastic rheumatic syndromes
-
Fortin P. Paraneoplastic rheumatic syndromes. Curr. Opin. Rheumatol. 8 1 (1996) 30-33
-
(1996)
Curr. Opin. Rheumatol.
, vol.8
, Issue.1
, pp. 30-33
-
-
Fortin, P.1
-
41
-
-
0034534016
-
Temporal concurrence of vasculitis and cancer: a report of 12 cases
-
Hutson T., and Hoffman G. Temporal concurrence of vasculitis and cancer: a report of 12 cases. Arthritis. Care. Res. 13 6 (2000) 417-423
-
(2000)
Arthritis. Care. Res.
, vol.13
, Issue.6
, pp. 417-423
-
-
Hutson, T.1
Hoffman, G.2
-
42
-
-
0343953394
-
Cutaneous vasculitis and cancer: a clinical approach
-
González-Gay M., et al. Cutaneous vasculitis and cancer: a clinical approach. Clin. Exp. Rheumatol. 18 3 (2000) 305-307
-
(2000)
Clin. Exp. Rheumatol.
, vol.18
, Issue.3
, pp. 305-307
-
-
González-Gay, M.1
-
43
-
-
0037380435
-
The spectrum of cutaneous disease in multiple myeloma
-
Bayer-Garner I., and Smoller B. The spectrum of cutaneous disease in multiple myeloma. J. Am. Acad. Dermatol. 48 4 (2003) 497-507
-
(2003)
J. Am. Acad. Dermatol.
, vol.48
, Issue.4
, pp. 497-507
-
-
Bayer-Garner, I.1
Smoller, B.2
-
44
-
-
0022725087
-
Paraneoplastic vasculitis. Unique syndrome of cutaneous angiitis and arthritis associated with myeloproliferative disorders
-
Longley S., Caldwell J., and Panush R. Paraneoplastic vasculitis. Unique syndrome of cutaneous angiitis and arthritis associated with myeloproliferative disorders. Am. J. Med. 80 (1986) 1027-1031
-
(1986)
Am. J. Med.
, vol.80
, pp. 1027-1031
-
-
Longley, S.1
Caldwell, J.2
Panush, R.3
-
45
-
-
0030988771
-
Mucocutaneous paraneoplastic syndromes
-
Cohen P., and Kurzrock R. Mucocutaneous paraneoplastic syndromes. Semin. Oncol. 24 3 (1997) 334-359
-
(1997)
Semin. Oncol.
, vol.24
, Issue.3
, pp. 334-359
-
-
Cohen, P.1
Kurzrock, R.2
|